Awareness, Attitudes and Clinical Practices Regarding Human Papillomavirus Vaccination among General Practitioners and Pediatricians in Switzerland

In Switzerland, the human papillomavirus vaccination (HPVv) coverage rate lies below a desirable threshold. General practitioners (GPs) and pediatricians have been recognized as important providers of the HPVv, but there is little known about their self-attributed role and its relationship with their actual HPVv behavior. Therefore, the objective of this study was to explore the awareness, attitudes, and clinical practices of Swiss GPs and pediatricians concerning HPVv by means of a web-based questionnaire. We analyzed the responses of 422 physicians (72% GPs, 28% pediatricians). A substantial proportion of respondents considered the HPVv absolutely essential (54.2% of pediatricians, 30.6% of GPs). GPs indicated spending more time and effort on HPVv counseling for female rather than male patients more often compared to pediatricians (44.0% versus 13.9%, p < 0.001). The weekly number of patients aged 18-26 years seen in practice (p = 0.002) and whether the HPVv was deemed absolutely essential (adjusted odds ratio 2.39, 95% confidence interval 1.12-5.08) were factors associated with GPs administering HPVv in their practice. Shortcomings in terms of awareness, effort in the identification of potential vaccination candidates, and the role of male patients were revealed. By addressing these gaps, Swiss primary care providers could contribute to an increase in the national HPVv coverage rate.

Automated summary

In Switzerland, there is a lower-than-desirable human papillomavirus vaccination coverage rate with general practitioners (GPs) and pediatricians playing important roles as providers of the HPV vaccine. However, differences in awareness, attitudes, and practices exist between GPs and pediatricians, with GPs showing more focus on HPV counseling for female patients. Factors influencing physicians' HPV vaccination practices include the number of patients seen and the perceived importance of the vaccine. Addressing these gaps in awareness and practice could help increase national HPV vaccination coverage rates.